Bronchiolitis in Infants Placebo Versus Dexamethasone Study
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Bronchiolitis in Infants Placebo Versus Dexamethasone Study is a clinical trial[1].
Key Facts
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study is in the country of Australia[2].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study is in the country of Canada[3].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study is in the country of New Zealand[4].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study's instance of is recorded as clinical trial[5].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study's start time is recorded as +2018-12-13T00:00:00Z[6].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study's end time is recorded as +2022-10-31T00:00:00Z[7].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study's sponsor is recorded as Children's Hospital of Eastern Ontario[8].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study's main subject is recorded as bronchiolitis[9].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study's number of participants is recorded as {'unit': '1', 'amount': '+1616'}[10].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study's title is recorded as A Randomized Controlled Trial Comparing Epinephrine and Dexamethasone to Placebo in the Treatment of Infants With Bronchiolitis[11].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study's short name is recorded as BIPED[12].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study's ClinicalTrials.gov ID is recorded as NCT03567473[13].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q5151', 'amount': '+12'}[14].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study's research intervention is recorded as (RS)-cyclophosphamide[15].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study's research intervention is recorded as dexamethasone acetate[16].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study's research intervention is recorded as (±)-adrenaline[17].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study's research intervention is recorded as racepinephrine hydrochloride[18].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study's research intervention is recorded as epinephryl borate[19].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study's clinical trial phase is recorded as phase III clinical trial[20].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study's research site is recorded as University of Alberta[21].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study's research site is recorded as Waikato Hospital[22].
- Bronchiolitis in Infants Placebo Versus Dexamethasone Study's study type is recorded as interventional study[23].